ChartRow logo
ADPT
$24.42+1.96%
as of close, Oct 20, 2026
☾ AH $24.42 +1.96%
PeersRVTYSPYQQQNVDAAAPLMSFT
Share this page

Adaptive Biotechnologies Corporation trailing returns

How Adaptive Biotechnologies Corporation (ADPT) has performed over the last day, week, month and year, over 5 years, and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day+2.0%+0.0%+2.0%—
5 days-3.4%+0.0%-3.4%-6.5%Oct 19
1 month-14.6%+0.0%-14.6%-19.7%Oct 19
YTD+50.4%+0.0%+50.4%-35.5%Mar 27
1 year+37.0%+0.0%+37.0%-39.3%Mar 2026
5 years-6.4%+0.0%-6.4%-28.0%-93.7%Apr 2024
Since inception (2019)-6.6%+0.0%-6.6%-39.4%-96.6%Apr 2024

Growth of ADPT#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years-6.4%/year · -28.0%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in ADPT's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Adaptive Biotechnologies Corporation's return since inception?
Since 2019, Adaptive Biotechnologies Corporation (ADPT) has compounded at about -6.6% a year — -39.4% in total.

More on Adaptive Biotechnologies Corporation